White Brook Capital – SMTI
Bull thesis on Sanara Medtech from White Brook Capital
Cedar Grove Capital Management – SNWV
Bull thesis on Sanuwave Health from Cedar Grove Capital Management
Davis Global Fund SVM
Bull thesis on Solventum Corporation from Davis Global Fund
Sanuwave Health, Inc. (SNWV) – Tenva Capital
Pitch Summary: The author believes Sanuwave Health is deeply undervalued given its accelerating growth profile and the strengthening of its sales force. The company expanded from two sales representatives to nine in 2024 and plans to reach full national coverage with 12–13 in 2025, despite already delivering two consecutive years of 50% revenue growth with […]
Covalon (TSX-V: COV / OTCQX: CVALF) Fireside Chat with Mathieu Martin, Rivemont MicroCap Fund
- Company Pitch: Covalon Technologies (COV) is a Canadian medtech focused on helping patients heal faster and preventing costly complications, with ~$33M CAD revenue and strong EBITDA.
- Wound Care: The company’s collagen dressing is sold via an OEM model in a fragmented $10B market, driving low SG&A and meaningful growth runway in the US.
- Vascular Access: Hospital-focused portfolio shows high growth with consistent sequential gains, highlighted by the Valguard product addressing critical catheter use cases.
- Infection Prevention: Clinical data at Montefiore showed a >50% reduction in catheter-related bloodstream infections overall and 100% reduction in pediatric critical care, underscoring strong clinical and economic value.
- Competitive Landscape: Competes against large players (e.g., 3M spinoff, BD, J&J Ethicon, Smith & Nephew) and smaller entrants, with product differentiation and agility cited as advantages.
- AI Strategy: Management is deploying AI as a revenue force multiplier to scale customer-facing capabilities, in contrast to peers primarily using AI for cost reduction.
- Capital Allocation & Outlook: Announced a $0.15 special dividend amid rising cash, with continued investments in automation and openness to tuck-in M&A, buybacks, and future dividends.
Sanuwave Health Inc. (SNWV)
Pitch Summary: Sanuwave Health is a rapidly scaling medtech “distribution play” with a category-killer product (UltraMIST) for complex wound healing — a non-contact, ultrasound-based therapy that delivers vastly better outcomes (4x more effective, 5x fewer complications) at one-third the cost of standard care. Despite proven efficacy, adoption has been limited by historical execution failures, now […]
